Intra-arterial Y-90 Therapy for Liver Cancer
A Targeted Treatment for Liver Tumors
Y-90 therapy, also called Yttrium-90 radioembolization, is an advanced treatment used for cancers that involve the liver. It is commonly used for:
1. Primary liver cancer (Hepatocellular carcinoma – HCC)
2. Cancer that has spread to the liver from other organs such as colon, pancreas etc.
This treatment delivers radiation directly to the tumor inside the liver, helping destroy cancer cells while protecting most of the healthy liver tissue.
How Does Y-90 Therapy Work?
Liver tumors receive most of their blood supply from the hepatic artery, while normal liver tissue receives blood mainly from the portal vein. Y-90 therapy takes advantage of this difference.
During the procedure:
This approach allows high-dose radiation to the tumor while sparing most normal liver tissue.
What Does the Treatment Involve?
What Are the Benefits of Y-90 Therapy?
Y-90 therapy offers several advantages:
1. Highly targeted treatment
2. Delivers radiation directly to the tumor
3. Minimal damage to healthy liver tissue
4. Can shrink tumors and slow disease progression
5. May help control symptoms and improve quality of life
6. In some cases, can reduce tumor size enough to make surgery or transplant possible
Possible Side Effects
Most patients tolerate Y-90 therapy well. Some temporary side effects may include:
1. Mild fatigue
2. Low-grade fever
3. Abdominal discomfort
4. Nausea or reduced appetite
These symptoms are usually mild and resolve within a few days.
Recovery After the Procedure
Most patients can return to normal activities within a few days.
Follow-up includes:
A Personalized Approach to Liver Cancer Treatment
If you or your loved one has liver cancer, our doctor can help determine whether Y-90 radioembolization is an appropriate option.
Subsribe To Our Newsletter
Stay in touch with us to get latest news at Theranostic